Lauren A. Daniel
@5am Venture Management, Llc
Latest period2024 - Q3ReportedManaged Assets$484.005MTotal holdings28
Assets growth rate8.26%Assets growth rate (2-Q avg)4.19%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in 5am Venture Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 28 positions.
Assets under management
The assets under management (AUM) of 5am Venture Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 484.005M in assets, with a quarterly growth rate of 8.26% and a 2-quarter average growth rate of 4.19%. The portfolio is managed by Lauren A. Daniel, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CLDXCelldex Therapeutics Inc New
| 3.5% | $16.902M 497,270 shares@ $33.99 avg price | |
VRDNViridian Therapeutics Inc
| 3.47% | $16.758M 736,595 shares@ $22.75 avg price | |
VKTXViking Therapeutics Inc
| 3.11% | $15.04M 237,560 shares@ $63.32 avg price | |
PHVSPharvaris N V
| 3.06% | $14.772M 797,600 shares@ $18.52 avg price | |
ERASErasca Inc
| 3.05% | $14.757M 5.405M shares@ $2.74 avg price | |
MLTXMoonlake Immunotherapeutics
| 2.95% | $14.234M 282,313 shares@ $50.42 avg price | |
ANABAnaptysbio Inc
| 2.48% | $11.984M 357,733 shares@ $33.51 avg price | |
SLNSilence Therapeutics Plc
| 1.79% | $8.657M 476,200 shares@ $18.18 avg price | |
EYPTEyepoint Pharmaceuticals Inc
| 1.74% | $8.389M 1.05M shares@ $7.99 avg price | Increased 2000% |
COGTCogent Biosciences Inc
| 1.26% | $6.068M 561,854 shares@ $10.8 avg price | Decreased -28.91% |